Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 Diabetes is a research paper published in medRxiv (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: N01 AI015416
NIDDK NIH HHS
Grant: P30 DK097512
NIAID NIH HHS
Grant: UM1 AI109565
Keywords